These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12833082)

  • 1. Why RNAi makes sense.
    Hough SR; Wiederholt KA; Burrier AC; Woolf TM; Taylor MF
    Nat Biotechnol; 2003 Jul; 21(7):731-2. PubMed ID: 12833082
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progression of RNA interference technology and its application in the research of gene function and gene therapy].
    Lü H; He ZM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):102-5. PubMed ID: 15871202
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application of RNAi to cancer therapy].
    Tan YL; Yin JQ
    Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
    [No Abstract]   [Full Text] [Related]  

  • 5. RNA interference in cancer.
    Gartel AL; Kandel ES
    Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference for therapy in the vascular endothelium.
    Kaufmann J; Ahrens K; Santel A
    Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference as an anticancer therapy: a patent perspective.
    Dykxhoorn DM
    Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in cell-type specific delivery of RNAi-based therapeutics.
    Dykxhoorn DM
    IDrugs; 2010 May; 13(5):325-31. PubMed ID: 20432190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatological applications of gene silencing RNA technology.
    Slater DN
    Br J Dermatol; 2011 May; 164(5):939. PubMed ID: 21518325
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
    Paulson H
    Neurology; 2006 Jan; 66(2 Suppl 1):S114-7. PubMed ID: 16432138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
    Wang SL; Yao HH; Guo LL; Dong L; Li SG; Gu YP; Qin ZH
    Cancer Genet Cytogenet; 2009 Apr; 190(1):8-14. PubMed ID: 19264227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting siRNA to arrest fibrosis.
    Friedman SL
    Nat Biotechnol; 2008 Apr; 26(4):399-400. PubMed ID: 18392021
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the human genome.
    Tachikawa K; Briggs SP
    Curr Opin Biotechnol; 2006 Dec; 17(6):659-65. PubMed ID: 17085035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ex-vivo application of RNAi for neuroscience.
    Baskin L; Urschel S; Eiberger B
    Biotechniques; 2008 Sep; 45(3):338-9. PubMed ID: 18778260
    [No Abstract]   [Full Text] [Related]  

  • 19. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.